Prioritise what Sitora should test next, without confusing scale with recoverability.

Observed signal

~30,000 patients per year staying at least 21 days beyond discharge-ready date; NHS England identified up to 500,000 bed days for release.

Opportunity

Reduce avoidable days after discharge readiness by identifying the active constraint, assigning a named owner and escalating unresolved cross-system dependencies in real time.

Operational owner

Acute trust + community provider + ICB + local authority

Intervention

Daily constraint coding, named ownership, care-transfer-hub escalation, early downstream activation and verified closure of the blocking dependency.

Pilot readiness: Ready now

Minimum data needed

• Discharge-ready timestamp
• Primary delay reason
• Named dependency owner
• Resolution timestamp
• Destination/pathway
• Additional bed days

What proves recovery

• Bed days after readiness
• Median delay by cause
• Same-day discharge after readiness
• Recurrent cause rate
• Capacity actually reused

Safety / interpretation guardrails

• No unsafe acceleration of discharge
• Track readmission and safeguarding outcomes
• Do not treat social-care constraints as provider failure

Observed signal

Millions of elective appointments are missed each year; NHS England has described DNAs as a major recoverable capacity problem and has published interventions that can reduce them quickly.

Opportunity

Recover booked clinical capacity before it becomes idle by reducing cancellation friction, identifying high-risk appointments and filling released slots rapidly.

Operational owner

Trust elective operations + specialty teams

Intervention

Two-way reminders, easy cancellation, short-notice waiting lists, risk-based reminder intensity and same-day backfill workflows.

Pilot readiness: Ready now

Minimum data needed

• Appointment date
• Booking lead time
• Reminder delivery
• Cancellation timing
• DNA reason
• Whether slot was backfilled

What proves recovery

• DNA rate
• Backfill rate
• Additional patients seen
• Unused clinician minutes
• Waiting-time effect

Safety / interpretation guardrails

• Do not penalise vulnerable patients
• Monitor inequalities by deprivation, disability and language
• Separate patient access barriers from behavioural assumptions

Observed signal

16 million GP appointments were not attended in 2025, equivalent to 4.3% of appointments.

Opportunity

Recover primary-care capacity by identifying preventable non-attendance and making cancellation/rebooking and short-notice refill substantially easier.

Operational owner

Practices + PCNs + ICB primary care

Intervention

App/push reminders, one-tap cancellation, short-notice wait lists and targeted reminder intensity.

Pilot readiness: Ready now

Minimum data needed

• Appointment type
• Lead time
• Reminder delivery
• DNA
• Cancellation timing
• Backfill status

What proves recovery

• DNA rate
• Appointments backfilled
• Clinician minutes reused
• Waiting-time change

Safety / interpretation guardrails

• Protect access for vulnerable groups
• Do not use punitive cancellation rules
• Analyse inequality effects

Observed signal

Theatre utilisation has improved, but NHS England continues to identify theatre productivity and variation as a major source of further productivity gain.

Opportunity

Convert unexplained list-time loss into a minute-level operational dataset so repeated causes can be acted on and recovered time can be shown as additional usable surgical capacity.

Operational owner

Theatre operations + surgical divisions

Intervention

Common delay taxonomy, list-readiness checks, predictive scheduling, turnaround tracking and live escalation of recoverable gaps.

Pilot readiness: Ready now

Minimum data needed

• Planned and actual start
• Case duration
• Turnaround
• Cancellation reason
• Staff/equipment readiness
• List finish

What proves recovery

• Touch-time utilisation
• Late-start minutes
• Turnaround minutes
• Cases per list
• Cancelled cases
• Recovered minutes converted to activity

Safety / interpretation guardrails

• Do not incentivise unsafe speed
• Track overruns and staff fatigue
• Case-mix adjust comparisons

Observed signal

Agency spend fell from about £2.1bn in 2024/25 to about £1.2bn in 2025/26, proving that this cost base can change materially while leaving a substantial residual spend to understand.

Opportunity

Separate clinically necessary temporary staffing from recurrent avoidable premium use and target the specific roster, vacancy, retention or bank-fill causes.

Operational owner

Trust workforce + finance + divisional management

Intervention

Shift-level causal coding, bank-first escalation, roster analytics, hotspot recruitment and retention interventions.

Pilot readiness: Ready now

Minimum data needed

• Agency shift
• Premium vs bank/substantive
• Reason agency used
• Bank fill attempts
• Vacancy age
• Specialty

What proves recovery

• Agency spend
• Premium avoided
• Bank fill rate
• Unfilled shifts
• Safety/quality indicators

Safety / interpretation guardrails

• Do not create unsafe gaps
• Track staff workload
• Attribute savings only where premium use is actually displaced

Observed signal

National modelling identified >4,000 WTE nursing capacity and >1 million bed days potentially releasable, alongside major aseptic productivity opportunity.

Opportunity

Move suitable medicines away from unnecessarily labour-intensive preparation and administration while reducing prepared-but-unused doses and cleanroom bottlenecks.

Operational owner

Chief pharmacist + aseptic service + clinical divisions

Intervention

Ready-to-administer conversion, dose banding, route optimisation, hub-and-spoke supply and prepared-dose waste measurement.

Pilot readiness: Ready with data

Minimum data needed

• Product and presentation
• Preparation time
• Nursing administration time
• Prepared-but-unused doses
• Chair/bed time
• Acquisition cost

What proves recovery

• Nursing minutes released
• Aseptic slots released
• Unused doses
• Chair/bed time released
• Net pathway cost

Safety / interpretation guardrails

• Clinical equivalence first
• Supply resilience
• Stability/storage controls
• Do not count modelled capacity as realised until reused

Observed signal

NHS services continue to campaign against unnecessary repeat ordering, while digital repeat ordering has reached very large scale. The current national avoidable value is not measured robustly.

Opportunity

Close the gap between prescribing, dispensing and actual patient need so avoidable repeat supply can be prevented before dispensing rather than discovered as returned waste.

Operational owner

Primary care + community pharmacy + ICB medicines optimisation

Intervention

Patient stock confirmation, medication-change reconciliation, anomaly detection and pharmacist review before repeat items are authorised or dispensed.

Pilot readiness: Ready with data

Minimum data needed

• Repeat item ordered
• Last dispense date
• Expected consumption
• Patient-held stock
• Recent medication changes
• Hospital discharge changes

What proves recovery

• Items safely not dispensed
• Avoided acquisition cost
• Pharmacist interventions
• Emergency re-supply
• Medication safety events

Safety / interpretation guardrails

• Never auto-stop essential medication
• Clinical/pharmacy review for exceptions
• Monitor under-supply and adherence harms

Observed signal

NHS England has identified substantial annual patient-communications expenditure while promoting lower-cost NHS App messaging and digital-by-default workflows.

Opportunity

Shift suitable communications from paid channels to secure digital delivery while protecting patients who require paper, phone or accessible formats.

Operational owner

Provider digital + communications + outpatient operations

Intervention

Channel-cost measurement, consent/availability routing, NHS App-first messaging and automatic fallback only where required.

Pilot readiness: Ready now

Minimum data needed

• Message type
• Channel
• Unit cost
• Delivery status
• Digital eligibility
• Fallback reason

What proves recovery

• Paid messages avoided
• Net communications cost
• Delivery/read rate
• Failure/fallback rate
• Access complaints

Safety / interpretation guardrails

• No digital exclusion
• Accessible-format support
• Clinical urgency must override cheapest channel

Observed signal

Provider drug spending has shown material adverse variance to plan, but the amount that is genuinely avoidable cannot be inferred from overspend alone.

Opportunity

Decompose drug-cost growth into price, volume, case mix, new therapies and potentially unwarranted variation before targeting procurement or prescribing change.

Operational owner

Chief pharmacist + finance + commissioning

Intervention

Price-volume-mix decomposition, biosimilar/brand analysis, procurement comparison and pathway-level prescribing variation review.

Pilot readiness: Ready with data

Minimum data needed

• Drug spend by molecule
• Volume
• Unit price
• Indication
• Case mix
• Contract price
• Comparator providers

What proves recovery

• Variance explained
• Avoidable component
• Unit-price change
• Prescribing change
• Clinical outcome safeguards

Safety / interpretation guardrails

• Never equate overspend with waste
• Protect access to clinically indicated innovation
• Case-mix adjust comparisons

Observed signal

Hospital treatment for preventable dental disease remains a substantial downstream burden, but the resource benefit of a new school/community detection pathway requires prospective evaluation.

Opportunity

Detect risk and visible disease earlier, complete referral loops and test whether earlier intervention reduces later urgent and hospital treatment without creating a new referral bottleneck.

Operational owner

ICB dental commissioning + schools + community dental services

Intervention

Structured periodic check, appropriate imaging where validated, parent communication and closed-loop referral to qualified dental review.

Pilot readiness: Needs design

Minimum data needed

• Baseline oral-health risk
• Screen finding
• Referral
• Attendance
• Treatment completed
• Later urgent/hospital activity

What proves recovery

• Completed referrals
• Earlier-stage treatment
• Urgent attendance
• Hospital extraction rate
• Net pathway cost

Safety / interpretation guardrails

• Screening is not diagnosis
• Parental consent
• Avoid overwhelming existing dental capacity
• Clinical governance and device regulation